Hormone Replacement Therapy Near You: What to Verify Before You Book

Checking a local hormone clinic

Key point: Licensing, monitoring frequency and whether the product is FDA-approved separate clinics faster than price does.

What a good provider should make clear: A clinic that names the prescriber, the product, and the monitoring schedule before taking payment.

Common mistake: Choosing on the consultation being free. The free consultation is the sales call.

Questions to ask: Who is the prescribing clinician, and what is the monitoring schedule?

The four checks, in order

1. Licence. Who prescribes, in what discipline, licensed in which state? Verify it on the state board's own site, not the clinic's.
2. Product. Is the medication an FDA-approved product or a compounded preparation? The FDA states that "Compounded drugs are not FDA-approved" and that it "does not verify the safety, effectiveness or quality of compounded drugs before they are marketed".
3. Monitoring. Which labs, at what intervals, reviewed by whom? A programme that does not repeat labs is not monitoring anything.
4. Fee contents. What is inside the monthly figure and what arrives as a separate bill?

Why the monitoring question does the most work

Hormone therapy is a long-running prescription, not a one-off purchase. The value of a clinic is largely in its follow-up.

Ask how often testosterone, blood count and metabolic panels are repeated, and what result would cause the dose to change.

A clinic that cannot answer that has sold you a subscription rather than a treatment plan.

Telehealth or local, and what each one is priced on

Telehealth suits stable, straightforward cases where the labs can be drawn anywhere.

A local clinic matters more when injections or pellet placement are part of the plan, or when a physical examination is likely to change the decision.

The components that a local visit adds are the ones with published prices. Nationally, in the office setting:

Use these to test any claim about the value of what a local programme bundles in. A monthly fee well above the sum of its published parts is buying you access and follow-up, which may be worth it — but you should know that is what you are buying.

Questions to ask on the first call

• Who is the prescribing clinician and where are they licensed?
• Is the product FDA-approved or compounded?
• What is the lab schedule for the first year?
• What does the fee include, and what does it not?
• What is the process for stopping?

Common mistake: letting a free consultation set the agenda before any of these are answered.

Where these numbers come from, and what they are not

Source: Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners — by Geography and Service, calendar year 2024 claims (file released 21 May 2026).

Method: we pull the published rows for each billing code, keep the average submitted charge and the average Medicare allowed amount, and print them unchanged. Nothing is modelled, averaged across codes, or adjusted.

• The submitted charge is what clinicians billed. It is list price. Almost nobody pays it.
• The allowed amount is what Medicare permitted, including the patient's coinsurance. It is a negotiated price.
• These are Medicare fee-for-service claims. The patients skew 65 and older.
• If you are paying cash or using commercial insurance, neither figure is your price. Use the gap between them as a bargaining range, not a quote.
• CMS hides any cell covering fewer than 11 patients, so some states are missing. We print "not published" there rather than guessing.

Common mistake: reading the allowed amount as "the real price" and expecting a clinic to match it. It is what one payer pays one set of clinicians.